Year: 2026

HanLink initiative builds on progress in Saudi Arabia and aligns with Ruanyun’s ongoing globalization strategy, planned branding transition to Formind Group, and set target of deriving approximately 60% of revenue from international markets by the end of 2027. NANCHANG, China, April 22, 2026 (GLOBE NEWSWIRE) — Ruanyun Edai Technology Inc. (NASDAQ: RYET) (“Ruanyun Edai Technology,” “RYET,” or the “Company”), an AI-driven education technology company focused on intelligent content recognition, automated assessment and next-generation learning systems, today announced the launch of a pilot project with the Center on Chinese Education at Teachers College, Columbia University as part of its broader expansion into educational institutional support services. The pilot project, implemented through the Center on Chinese Education at Teachers...

SOUTHLAKE, Texas, April 22, 2026 (GLOBE NEWSWIRE) — American Fusion Inc. (OTC: AMFN) (“American Fusion” or the “Company”), an advanced energy platform company focused on fusion energy technologies, reports continued progress in the development and expansion of its intellectual property portfolio supporting its Texatron™ fusion platform, including ongoing engagement with the U.S. Patent and Trademark Office and preparation for a significant increase in patent filings. The Company’s Chief Legal Officer, Micheal Smith is currently responding to communications from the U.S. Patent and Trademark Office related to its existing patent applications and continues to advance a portfolio that includes approximately 280 patent filings in progress covering key aspects of its reactor design, supporting systems, and enabling technologies. In...

ISELIN, N.J., April 22, 2026 (GLOBE NEWSWIRE) — Outlook Therapeutics, Inc. (Nasdaq: OTLK) (“Outlook Therapeutics” or the “Company”), a biopharmaceutical company focused on enhancing the standard of care for bevacizumab for the treatment of retina diseases, today announced that it has entered into a definitive agreement for the purchase and sale of an aggregate of 16,129,033 shares of its common stock (or pre-funded warrants in lieu thereof) at an offering price of $0.31 per share of common stock (or per pre-funded warrants in lieu thereof) in a registered direct offering priced at-the-market under Nasdaq rules. Additionally, in a concurrent private placement, the Company will issue unregistered warrants to purchase up to an aggregate of 16,129,033 shares of common stock at an exercise price of $0.31 per share. The unregistered warrants...

Binding Facility for Strategic Equinex/AtNorth Data Center Build Out in Sweden Road Town, Tortola, British Virgin Islands, April 22, 2026 (GLOBE NEWSWIRE) — Alpha Compute Corp. (Nasdaq: ALP), a pioneer in AI Confidential Compute and GPU-as-a-Service (GPUaaS), today announced the execution of a binding term sheet for a $31.9 million non-recourse loan facility secured by B300 Nvidia graphics processing units (GPUs). The transaction marks a significant milestone in the Company’s strategy to scale its AI compute capabilities while optimizing its capital structure. The executed term sheet, entered into with an undisclosed institutional lender, establishes the parameters for a structured credit facility. In this facility, the collateral is strictly limited to the underlying Nvidia GPU assets and the facility’s build-out. Given...

XBP Global Appoints Acquelia Colaco as Chief Human Resources OfficerXBP Global Holdings, Inc. (“XBP Global” or “the Company”) (NASDAQ: XBP), announced the appointment of Acquelia Colaco as its Chief Human Resources Officer (CHRO).Acquelia will lead the global people’s agenda across the Americas, Europe, and Asia, with a mandate to align talent, leadership, and culture to this next phase of AI-led transformation.IRVING, Texas, April 22, 2026 (GLOBE NEWSWIRE) — XBP Global Holdings, Inc. (“XBP Global” or “the Company”) (NASDAQ: XBP), a multinational technology and services company orchestrating mission-critical systems that enable hyper-automation and digital transformation, announced the appointment of Acquelia Colaco as its Chief Human Resources Officer (CHRO). Acquelia will lead the global people’s agenda across...

BOCA RATON, Fla., April 22, 2026 (GLOBE NEWSWIRE) — Red Violet, Inc. (NASDAQ: RDVT), a leading analytics and information solutions provider, announced today that it will report its financial results for the first quarter ended March 31, 2026 after the close of the U.S. financial markets on Wednesday, May 6, 2026. The Company will host its earnings call on Wednesday, May 6, 2026, at 4:30pm ET to discuss its quarterly results and provide a business update. The participant registration and webcast information are listed below. The earnings call will be simultaneously webcast on the Investors section of the red violet website at www.redviolet.com. Please login at least 15 minutes prior to the start of the call to ensure adequate time for any downloads that may be required. Please note participants must register to receive their unique...

CAMPBELL, Calif., April 22, 2026 (GLOBE NEWSWIRE) — Arteris, Inc. (Nasdaq: AIP), a leading provider of semiconductor technology for accelerating innovation in the AI era, today announced it will release its financial results for the first quarter ended March 31, 2026, after market close on Tuesday, May 12, 2026. Management will host a conference call on Tuesday, May 12, 2026, at 4:30 PM ET to discuss these results. The call will be available, live, to interested parties by dialing:United States/Canada Toll Free: +1-800-717-1738International Toll: +1-646-307-1865   Please join the call 5-10 minutes prior to the scheduled start time to avoid a delay in connecting. A live webcast will be available in the Investor Relations section of Arteris’ website at: https://ir.arteris.com/events-and-presentations. A replay of the webcast...

CONSHOHOCKEN, Pa., April 22, 2026 (GLOBE NEWSWIRE) — Madrigal Pharmaceuticals, Inc. (Nasdaq: MDGL) announced today that it will release its first-quarter 2026 financial results on Wednesday, May 6, 2026, prior to the open of the U.S. financial markets. Following the announcement, Madrigal’s management will host a live webcast at 8 a.m. Eastern Time to review the Company’s financial and operating results. The live webcast may be accessed at the Investor Relations section of the Madrigal Pharmaceuticals website. To ensure a timely connection, it is recommended that participants register at least 15 minutes prior to the scheduled webcast. The webcast will be available approximately two hours after the live webcast. About Madrigal PharmaceuticalsMadrigal Pharmaceuticals, Inc. (Nasdaq: MDGL) is a biopharmaceutical company focused on...

MCDONALD, Tenn., April 22, 2026 (GLOBE NEWSWIRE) — Amaero Ltd (ASX:3DA, OTCX:AMROF) (“Amaero” or the “Company”), a leading producer of high-value refractory and titanium alloy powders for additive and advanced manufacturing, and a leader in PM-HIP (Powder Metallurgy Hot Isostatic Pressing) manufacturing, is pleased to share a recording of the Investor Webinar held on April 20, 2026 at 9:00 pm ET. Shareholders can view the recording here: https://investorhub.amaero.com.au/activity-updates/P7pJEy-amaero-ltd-asx-3da-investor-webinar-21-april-2026 This announcement has been authorized for release by the Chairman and CEO. For further information, please contact:Amaero LtdHank J. Holland Chairman and CEOhank.holland@amaeroinc.com Media & Investor Enquiries in AustraliaJane Morgan Directorjm@janemorganmanagement.com.au Media &...

Rich Heyman to retire from PMV Pharma Board of Directors; Laurie Stelzer, Director since 2020, appointed as new Chair PRINCETON, N.J., April 22, 2026 (GLOBE NEWSWIRE) — PMV Pharmaceuticals, Inc. (“PMV Pharma” or the “Company”; Nasdaq: PMVP), a precision oncology company pioneering the discovery and development of small molecule therapies targeting p53, today announced a leadership transition on its Board of Directors. Laurie Stelzer, who has served as a member of the Board since 2020, has been appointed Chair of the Board, succeeding Rich Heyman, Ph.D., effective at the Company’s 2026 Annual Meeting of Stockholders on June 4, 2026 (the “Meeting”). Dr. Heyman’s term as a member and Chair of the Board will expire at the Meeting, and Dr. Heyman will not stand for reelection. Ms. Stelzer brings more than 25 years of senior finance and...